<DOC>
	<DOCNO>NCT00914316</DOCNO>
	<brief_summary>The goal study evaluate whether supervise treadmill exercise combine ranolazine 1000 mg twice daily provide incremental benefit absolute walk distance supervise exercise alone patient stable claudication . Investigators also seek determine administration ranolazine provide sustained benefit completion supervise exercise regimen . Lastly , investigator wish determine whether exercise ranolazine improve peak oxygen consumption anaerobic threshold patient stable claudication .</brief_summary>
	<brief_title>Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities</brief_title>
	<detailed_description>The treatment group : A . Group A randomize 12 week supervise exercise program ranolazine , ( Ranexa ) 1000 mg orally , twice daily , mouth . B . Group B randomize 12 week supervise exercise program placebo . After 12 week supervise exercise program , participant undergo second randomization ranolazine placebo additional 12 week , independent walk encourage . Both group participate two week lead-in period randomization trial , allow stabilization medication dose ranolazine . Medications cilostazol , calcium channel blocker nitrate discontinued lead-in period , unless use management high blood pressure . Anti-platelet ( blood thinner ) medication continue throughout trial .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Males female great 40 year age . Documented peripheral arterial disease Stable low extremity intermittent claudication ( Rutherford class 13 ) 3 month . Critical limb ischemia ( Rutherford class 46 ) . Percutaneous surgical low extremity revascularization within last 12 month . Myocardial infarction within last 6 month . cardiac surgery within last 6 month . Unstable angina Stable chronic angina New York Heart Association Class IIIV heart failure Left ventricular ejection fraction less equal 35 % Venous thromboembolism within last 6 month . Uncontrolled high blood pressure , define systolic blood pressure great equal 180 mmHg diastolic blood pressure great equal 110 mmHg . Allergy ranolazine . QTc great equal 440 m male 460 ms female . Pregnant nursing female . Chronic dialysis therapy . Significant liver impairment ( defined transaminase great equal 3 time upper limit normal ) within last 6 month . Concomitant use CYP3A inhibitor Concomitant use CYP3A inducer QTc prolong agent Orthopedic neurologic disorder prevent treadmill walk . Current participation structure exercise program .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Lower leg claudication</keyword>
	<keyword>Poor circulation leg muscle</keyword>
	<keyword>Cramping discomfort low leg</keyword>
	<keyword>Lower leg pain</keyword>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>PAD</keyword>
</DOC>